Field evaluation of WALS truck-mounted A1 super duty mist sprayer® with VectoBac® WDG against Aedes aegypti (Diptera:Culicidae) populations in Manatee County, Florida

SN Appl Sci. 2022;4(2):50. doi: 10.1007/s42452-021-04893-x. Epub 2022 Jan 6.


Aedes aegypti, the Dengue and Zika vector, is a domestic mosquito that is difficult to control. The challenge lies in the mosquito's preference to lay its eggs in cryptic habitats such as fence post openings, buckets and bird baths, cups. Additionally, current methods of control are labor-intensive. We employed the WALS strategy to evaluate the operational efficacy of applying VectoBac WDG using a truck-mounted mister to control local populations of Ae. aegypti in urban settings with difficult-to-reach larval mosquito habitats. Our study was conducted in Cortez (Manatee County), Florida, USA (27° 27' N, 82° 40' W). We selected two study sites, one untreated control (21.9 ha) and one treatment site (23.1 ha) where historical data have shown high populations of Ae. aegypti based on weekly ovitrap surveillance. Weekly BGs and ovitraps (10-15 traps/site) were deployed to monitor adult population dynamics. A total of 50 bioassay jars were placed in the field each afternoon of the Bti application (8 application events) at fixed locations to collect droplets and gauge efficacy. We found significant reduction in female adults (P = 0.0002) and landing rate counts (P = 0.0058) as a result of treatment. Larval bioassays during the eight applications confirmed Bti deposit in a variety of coverage types regardless of placement in the yards. WALS applications with a truck-mounted mister can be effective at reducing disease carrying mosquito populations in residential areas and can be implemented in an integrated vector management program.

Supplementary information: The online version contains supplementary material available at 10.1007/s42452-021-04893-x.

Keywords: Adult surveillance; Bacillus thurigiensis israelensis; Egg surveillance; Insecticides; Integrated vector management; Organic; Ovitrap; Resistance.